Search
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
Invitrogen
LY3022855 Recombinant Human Monoclonal Antibody
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
产品信息
MA562704
应用
建议稀释比
已发表文章
产品规格
种属反应
Human
宿主/亚型
Human
/ IgG1, kappa
Expression System
CHO cells
分类
Recombinant Monoclonal
类型
Antibody
偶联物
形式
Liquid
浓度
1 mg/mL
纯化类型
Protein A/G
保存液
PBS, pH 7.4
内含物
no preservative
保存条件
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
运输条件
Ambient (domestic); Wet ice (international)
RRID
靶标信息
LY3022855 is a biosimilar human monoclonal antibody targeting the immune checkpoint ligand PD-L1 (Programmed Death-Ligand 1) which is crucial in the evasion of immune surveillance by cancer cells. Developed by Eli Lilly this biosimilar functions as an immune checkpoint inhibitor blocking the interaction between PD-L1 on tumor cells and PD-1 receptors on T cells thus enhancing immune-mediated tumor destruction. LY3022855 is an IgG1 antibody that has been formulated to increase specificity and improve immune system activation against cancer cells. Studies involving LY3022855 focus on its efficacy as a monotherapy or in combination with other treatments in clinical settings aiming to enhance anti-tumor responses. This biosimilar is involved in research exploring the potential for extended treatment responses in various oncological applications contributing to the advancement of therapies targeting immune checkpoints.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
篇参考文献 (0)
您是否在文献中引用过该产品？请点击下方按钮邮件告知我们。
